Company Overview of Ampersand Capital Partners
Ampersand Capital Partners is a private equity firm specializing in growth equity investments in middle market and buyout companies. The firm typically invests in healthcare and industrial sector. Within Industrial sector, it focuses on product and process design software, instrumentation for the chemical processing and environmental industries. Within healthcare sector, the firm focuses on, life sciences, pharmaceuticals, and biotechnology sectors. It typically invests between $10 million and $50 million per deal in companies with revenues between $10 million and $100 million. The firm prefers to be the first and lead institutional investor in its portfolio companies. Ampersand Capital Part...
55 William Street
Wellesley, MA 02481
Founded in 1988
Key Executives for Ampersand Capital Partners
Founder and Managing Partner
Chief Financial Officer and Chief Compliance Officer
Managing Partner and Managing General Partner
Compensation as of Fiscal Year 2014.
Ampersand Capital Partners Key Developments
Ampersand Capital Partners Adds Cecil Kost as Operating Partner
Jun 12 13
Ampersand Capital Partners announced the addition of Cecil Kost as an Operating Partner. Cecil will work with the Ampersand investment team to identify and evaluate new platform opportunities as well as assist on the existing portfolio. Most recently he served as President and CEO of Precision Dynamics Corp.
Ampersand Capital Partners Expands Management Team
Feb 25 13
Ampersand Capital Partners announced three additions to its management team. Eric Lev has joined the company as a partner, bringing over 12 years of middle market healthcare investing experience. Eric was most recently at Water Street Healthcare Partners where he served on the investment team since Water Street's formation in 2005. Prior to Water Street, Eric worked at Beckman Coulter and at One Equity Partners. Dana Niles has joined as the firm's CFO and Chief Compliance Officer. Prior to Ampersand, Dana served as CFO of HighPoint Capital. Before HighPoint, Dana served as Controller at both HLM Venture Partners and YankeeTek Ventures and as a Senior Auditor at Arthur Andersen. John Perkins has joined the company as an Operating Partner, where he will work with the investment team to identify and evaluate new platform opportunities. Most recently, John served as a senior executive at Talecris Biotherapeutics. Prior to Talecris, John held roles as an operating executive at Cerberus and as an executive at General Electric.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries